Srivathsan Badrinarayanan

Srivathsan Badrinarayanan, Chakradhar Guntuboina, Parisa Mollaei et al.

Peptides are essential in biological processes and therapeutics. In this study, we introduce Multi-Peptide, an innovative approach that combines transformer-based language models with Graph Neural Networks (GNNs) to predict peptide properties. We combine PeptideBERT, a transformer model tailored for peptide property prediction, with a GNN encoder to capture both sequence-based and structural features. By employing Contrastive Language-Image Pre-training (CLIP), Multi-Peptide aligns embeddings from both modalities into a shared latent space, thereby enhancing the model's predictive accuracy. Evaluations on hemolysis and nonfouling datasets demonstrate Multi-Peptide's robustness, achieving state-of-the-art 86.185% accuracy in hemolysis prediction. This study highlights the potential of multimodal learning in bioinformatics, paving the way for accurate and reliable predictions in peptide-based research and applications.

Srivathsan Badrinarayanan, Rishikesh Magar, Akshay Antony et al.

The discovery of Metal-Organic Frameworks (MOFs) with application-specific properties remains a central challenge in materials chemistry, owing to the immense size and complexity of their structural design space. Conventional computational screening techniques such as molecular simulations and density functional theory (DFT), while accurate, are computationally prohibitive at scale. Machine learning offers an exciting alternative by leveraging data-driven approaches to accelerate materials discovery. The complexity of MOFs, with their extended periodic structures and diverse topologies, creates both opportunities and challenges for generative modeling approaches. To address these challenges, we present a reinforcement learning-enhanced, transformer-based framework for the de novo design of MOFs. Central to our approach is MOFid, a chemically-informed string representation encoding both connectivity and topology, enabling scalable generative modeling. Our pipeline comprises three components: (1) a generative GPT model trained on MOFid sequences, (2) MOFormer, a transformer-based property predictor, and (3) a reinforcement learning (RL) module that optimizes generated candidates via property-guided reward functions. By integrating property feedback into sequence generation, our method drives the model toward synthesizable, topologically valid MOFs with desired functional attributes. This work demonstrates the potential of large language models, when coupled with reinforcement learning, to accelerate inverse design in reticular chemistry and unlock new frontiers in computational MOF discovery.

Tong Zeng, Srivathsan Badrinarayanan, Janghoon Ock et al.

Chemical process optimization maximizes production efficiency and economic performance, but optimization algorithms, including gradient-based solvers, numerical methods, and parameter grid searches, become impractical when operating constraints are ill-defined or unavailable. We present a multi-agent LLM framework that autonomously infers operating constraints from minimal process descriptions, then collaboratively guides optimization. Our AutoGen-based framework employs OpenAI's o3 model with specialized agents for constraint generation, parameter validation, simulation, and optimization guidance. Through autonomous constraint generation and iterative multi-agent optimization, the framework eliminates the need for predefined operational bounds. Validated on hydrodealkylation across cost, yield, and yield-to-cost ratio metrics, the framework achieved competitive performance with conventional methods while reducing wall-time 31-fold relative to grid search, converging in under 20 minutes. The reasoning-guided search demonstrates sophisticated process understanding, correctly identifying utility trade-offs and applying domain-informed heuristics. Unlike conventional methods requiring predefined constraints, our approach uniquely combines autonomous constraint generation with interpretable parameter exploration. Model comparison reveals reasoning-capable architectures (o3, o1) are essential for successful optimization, while standard models fail to converge. This approach is particularly valuable for emerging processes and retrofit applications where operational constraints are poorly characterized or unavailable.

Janghoon Ock, Radheesh Sharma Meda, Srivathsan Badrinarayanan et al.

We present a modular framework powered by large language models (LLMs) that automates and streamlines key tasks across the early-stage computational drug discovery pipeline. By combining LLM reasoning with domain-specific tools, the framework performs biomedical data retrieval, domain-specific question answering, molecular generation, property prediction, property-aware molecular refinement, and 3D protein-ligand structure generation. In a case study targeting BCL-2 in lymphocytic leukemia, the agent autonomously retrieved relevant biomolecular information, including FASTA sequences, SMILES representations, and literature, and answered mechanistic questions with improved contextual accuracy compared to standard LLMs. It then generated chemically diverse seed molecules and predicted 67 ADMET-related properties, which guided iterative molecular refinement. Across two refinement rounds, the number of molecules with QED > 0.6 increased from 34 to 55. The number of molecules satisfying empirical drug-likeness filters also rose; for example, compliance with the Ghose filter increased from 32 to 55 within a pool of 100 molecules. The framework also employed Boltz-2 to generate 3D protein-ligand complexes and provide rapid binding affinity estimates for candidate compounds. These results demonstrate that the approach effectively supports molecular screening, prioritization, and structure evaluation. Its modular design enables flexible integration of evolving tools and models, providing a scalable foundation for AI-assisted therapeutic discovery.

Srivathsan Badrinarayanan, Yue Su, Janghoon Ock et al.

Protein mutations can have profound effects on biological function, making accurate prediction of property changes critical for drug discovery, protein engineering, and precision medicine. Current approaches rely on fine-tuning protein-specific transformers for individual datasets, but struggle with cross-dataset generalization due to heterogeneous experimental conditions and limited target domain data. We introduce two key innovations: (1) the first application of Model-Agnostic Meta-Learning (MAML) to protein mutation property prediction, and (2) a novel mutation encoding strategy using separator tokens to directly incorporate mutations into sequence context. We build upon transformer architectures integrating them with MAML to enable rapid adaptation to new tasks through minimal gradient steps rather than learning dataset-specific patterns. Our mutation encoding addresses the critical limitation where standard transformers treat mutation positions as unknown tokens, significantly degrading performance. Evaluation across three diverse protein mutation datasets (functional fitness, thermal stability, and solubility) demonstrates significant advantages over traditional fine-tuning. In cross-task evaluation, our meta-learning approach achieves 29% better accuracy for functional fitness with 65% less training time, and 94% better accuracy for solubility with 55% faster training. The framework maintains consistent training efficiency regardless of dataset size, making it particularly valuable for industrial applications and early-stage protein design where experimental data is limited. This work establishes a systematic application of meta-learning to protein mutation analysis and introduces an effective mutation encoding strategy, offering transformative methodology for cross-domain generalization in protein engineering.